GSK joins with Singaporeans to mark SG50 golden jubilee milestone

SINGAPORE, August 9, 2015

Today marks the Republic of Singapore’s 50th year of independence. GSK extends warm wishes to the people and government of Singapore on this very special occasion.

Singapore is home to GSK’s Global Headquarters for Asia, two global primary manufacturing and supply sites, as well as a state-of-the-art vaccines facility.

GSK and Singapore have enjoyed a highly-productive partnership for over half-a-century and we are proud to have contributed to the development of Singapore’s manufacturing and healthcare sectors.

GSK was the first global healthcare company to establish a presence in Singapore and, in the years since, we have forged strong and mutually beneficial partnerships to grow our business and contribute to Singapore's thriving biomedical sciences industry.

The opening of Beecham’s (a legacy GSK company) facility in Jurong in 1973.
GSK opens its second manufacturing site in Singapore in 1982.

In 2012, GSK and Singapore’s Economic Development Board (EDB) jointly explored strategic investment options for GSK in Singapore that would be beneficial for both parties as part of our long-standing collaborative relationship.

This led to the formation of a GSK-EDB 10 year Singapore Manufacturing Roadmap that aims to guide the investment decisions and developmental work to ensure manufacturing remains a competitive edge for both GSK and Singapore.

Two of GSK’s manufacturing sites in Singapore today (above and below).

About GSK Singapore

Singapore is home to GSK’s Regional Headquarters (Emerging Markets & Asia Pacific), two global primary manufacturing and supply sites (Jurong & Quality Road) and a state-of-the-art vaccines plant (Tuas).